- Home
- TRNR vs XXII Comparison
TRNR vs XXII Comparison
Compare TRNR & XXII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRNR
- XXII
- Stock Information
- Founded
- TRNR 2017
- XXII 1998
- Country
- TRNR United States
- XXII United States
- Employees
- TRNR N/A
- XXII N/A
- Industry
- TRNR Consumer Electronics/Appliances
- XXII Medicinal Chemicals and Botanical Products
- Sector
- TRNR Technology
- XXII Health Care
- Exchange
- TRNR Nasdaq
- XXII Nasdaq
- Market Cap
- TRNR 3.9M
- XXII 2.8M
- IPO Year
- TRNR 2023
- XXII N/A
- Fundamental
- Price
- TRNR $1.33
- XXII $1.94
- Analyst Decision
- TRNR
- XXII
- Analyst Count
- TRNR 0
- XXII 0
- Target Price
- TRNR N/A
- XXII N/A
- AVG Volume (30 Days)
- TRNR 36.5M
- XXII 91.5K
- Earning Date
- TRNR 03-31-2025
- XXII 03-27-2025
- Dividend Yield
- TRNR N/A
- XXII N/A
- EPS Growth
- TRNR N/A
- XXII N/A
- EPS
- TRNR N/A
- XXII N/A
- Revenue
- TRNR $3,180,000.00
- XXII $17,304,000.00
- Revenue This Year
- TRNR $1,543.45
- XXII $56.94
- Revenue Next Year
- TRNR $54.84
- XXII $3.49
- P/E Ratio
- TRNR N/A
- XXII N/A
- Revenue Growth
- TRNR 226.82
- XXII N/A
- 52 Week Low
- TRNR $0.86
- XXII $1.68
- 52 Week High
- TRNR $1,640.00
- XXII $581.85
- Technical
- Relative Strength Index (RSI)
- TRNR 41.14
- XXII 31.27
- Support Level
- TRNR $1.33
- XXII $1.79
- Resistance Level
- TRNR $1.68
- XXII $2.08
- Average True Range (ATR)
- TRNR 0.67
- XXII 0.27
- MACD
- TRNR -0.00
- XXII 0.09
- Stochastic Oscillator
- TRNR 15.30
- XXII 17.45
About TRNR Interactive Strength Inc.
Interactive Strength Inc provides an integrated home fitness platform that allows its customers to participate in interactive wellness and strength-based training sessions. Its health coaching services encompass guidance and coaching on nutrition, recovery, sleep, and other health and lifestyle categories. The company generates revenue from sales of its connected fitness products, membership revenue, and personal training revenue.
About XXII 22nd Century Group Inc.
22nd Century Group Inc is a United States-based biotechnology company focused on utilizing alkaloid plant technologies to improve health and wellness with reduced nicotine tobacco, and hemp/cannabis. It has one operating segment; The tobacco segment is engaged in commercializing its proprietary VLNC tobacco plants and cigarette products, which contain nicotine than conventional tobacco and cigarettes, and research cigarettes sold under the brand name SPECTRUM. It derives a majority of its revenue from the tobacco segment.